Senior insider sale
Chief Executive Officer at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$3.80M
138K shares
What this filing means
COLOMA JASON V plans to sell 138K shares of MAZE THERAPEUTICS, INC. valued at approximately $3.80M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001969223-26-001044
DirectorOfficer· Chief Executive Officer
Since Mar 2026
138K
Shares to sell
$3.80M
Approx. market value
34.50K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months2
Gift
NA
9/22/2021
31.91KGift
NA
9/22/2021
2.59KTotal acquired34.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/22/2021 | Gift NA | 31.91K | Gift |
9/22/2021 | Gift NA | 2.59K | Gift |
| Total | 34.50K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
31.91K
Market value
$838.8K
9/1/2026
—Completed
Units to sell
2.59K
Market value
$68.2K
9/1/2026
—Completed
Units to sell
31.91K
Market value
$853.0K
8/3/2026
—Completed
Units to sell
2.59K
Market value
$69.3K
8/3/2026
—Completed
Units to sell
31.91K
Market value
$956.5K
7/1/2026
—Completed
Units to sell
2.59K
Market value
$77.7K
7/1/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
34.50K
Market value
$933.3K
10/1/2026
Total
Units
138K
Value
$3.80M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 31.91K | $838.8K | — | Completed |
9/1/2026 | 2.59K | $68.2K | — | Completed |
8/3/2026 | 31.91K | $853.0K | — | Completed |
8/3/2026 | 2.59K | $69.3K | — | Completed |
7/1/2026 | 31.91K | $956.5K | — | Completed |
7/1/2026 | 2.59K | $77.7K | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 34.50K | $933.3K | Nasdaq | Planned |
| Total | 138K | $3.80M | ||